Financial reports
10-Q
2024 Q1
Quarterly report
7 May 24
ARS
2023 FY
Annual report to shareholders
1 May 24
10-K
2023 FY
Annual report
12 Mar 24
10-Q
2023 Q3
Quarterly report
8 Nov 23
10-Q
2023 Q2
Quarterly report
9 Aug 23
10-Q
2023 Q1
Quarterly report
10 May 23
ARS
2022 FY
Annual report to shareholders
28 Apr 23
10-K
2022 FY
Annual report
15 Mar 23
10-Q
2022 Q3
Quarterly report
9 Nov 22
10-Q
2022 Q2
Quarterly report
10 Aug 22
Current reports
8-K
Departure of Directors or Certain Officers
12 Jun 24
8-K
MaxCyte Reports First Quarter 2024 Financial Results and Updates 2024 Guidance
7 May 24
8-K
MaxCyte Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 Guidance
12 Mar 24
8-K
MaxCyte Initiates Full Year 2024 Guidance and Reaffirms 2023 Preliminary Results
5 Mar 24
8-K
Departure of Directors or Certain Officers
26 Jan 24
8-K
MaxCyte Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Financial Results
8 Jan 24
8-K
MaxCyte Announces CEO Transition and Updates Revenue Guidance for 2023
11 Dec 23
8-K
MaxCyte Reports Third Quarter 2023 Financial Results and Reiterates Full Year 2023 Revenue Guidance
8 Nov 23
8-K
MaxCyte Announces Preliminary Third Quarter 2023 Revenue and Updates Full Year 2023 Revenue Guidance
4 Oct 23
8-K
MaxCyte Reports Second Quarter and Half-Year 2023 Financial Results and Updates Full Year 2023 Guidance
9 Aug 23
Registration and prospectus
S-8
Registration of securities for employees
14 Jul 22
S-8
Registration of securities for employees
5 Aug 21
424B4
Prospectus supplement with pricing info
30 Jul 21
S-1MEF
Registration of additional securities for an S-1
29 Jul 21
8-A12B
Registration of securities on exchange
27 Jul 21
S-1/A
IPO registration (amended)
26 Jul 21
S-1
IPO registration
9 Jul 21
DRS/A
Draft registration statement (amended)
25 Jun 21
DRSLTR
Correspondence regarding draft registration statement
25 Jun 21
DRS
Draft registration statement
14 May 21
Proxies
DEF 14A
Definitive proxy
26 Apr 24
DEF 14A
Definitive proxy
28 Apr 23
DEF 14A
Definitive proxy
26 May 22
DEF 14A
Definitive proxy
1 Oct 21
Ownership
144
Notice of proposed sale of securities
20 Jun 24
4
Art Mandell
13 Jun 24
4
RICHARD DOUGLAS
13 Jun 24
4
Rekha Hemrajani
13 Jun 24
4
Stanley C Erck
13 Jun 24
4
Yasir B. Al-Wakeel
13 Jun 24
4
John Joseph Johnston
13 Jun 24
4
PATRICK J BALTHROP
13 Jun 24
4
William W Brooke
13 Jun 24
4
Maher Masoud
10 Jun 24